E
Eliane Gluckman
Researcher at University of Paris
Publications - 694
Citations - 48573
Eliane Gluckman is an academic researcher from University of Paris. The author has contributed to research in topics: Transplantation & Bone marrow. The author has an hindex of 112, co-authored 679 publications receiving 46415 citations. Previous affiliations of Eliane Gluckman include Medical College of Wisconsin & Leiden University.
Papers
More filters
Book ChapterDOI
Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia
E. Jourdan,Dominique Maraninchi,Josy Reiffers,Eliane Gluckman,Bernard Rio,J P Jouet,Marie-Cécile Michallet,Molina L,E. Archimbaud,J L Harousseau,Norbert Ifrah,M. Attal,François Guilhot,M Kuentz,Denis Guyotat,Jose-Luis Pico,Charles Dauriac,Michel Legros,François Dreyfus,Pierre Bordigoni,Veronique Leblond,N. Gratecos,Bruno Varet,C. Auzanneau,H. Tilly,Etienne Vilmer,V.J. Bardou,Didier Blaise +27 more
TL;DR: A multivariate analysis showed that survival is adversely influenced by 3 independent factors: time to transplant, acute GVHD (grade 2–4 vs. grade 0–1) and age (≤33).
Journal ArticleDOI
Polyomavirus nephropathy in the native kidneys of an unrelated cord blood transplant recipient followed by a disseminated polyomavirus infection.
Susan Shapiro,Marie Robin,Helene Esperou,Agnès Devergie,Vanderson Rocha,Federico Garnier,Eliane Gluckman,Gérard Socié,Patricia Ribaud,Caroline Oudot,Catherine Scieux,Jeannine Cherot,Béatrice Mougenot,Tim Ulinski +13 more
Journal ArticleDOI
Extensive multilineage analysis in patients with mixed chimerism after allogeneic transplantation for sickle cell disease: insight into hematopoiesis and engraftment thresholds for gene therapy.
Alessandra Magnani,Corinne Pondarré,Naïm Bouazza,Jeremy Magalon,Annarita Miccio,Emmanuelle Six,Cécile Roudaut,Cécile Arnaud,Annie Kamdem,Fabien Touzot,Aurélie Gabrion,Elisa Magrin,Chloé Couzin,Mathieu Fusaro,Isabelle André,Jean-Paul Vernant,Eliane Gluckman,Françoise Bernaudin,Dominique Bories,Marina Cavazzana +19 more
TL;DR: Results show that myeloid chimerism as low as 30% was sufficient to prevent a vaso-occlusive crisis in transplants from an AA donor but not constantly from an AS donor, however, the correction of hemolysis requires higher donor chimerist levels in both AA and AS recipients.
Journal ArticleDOI
Secular Trends in Outcomes for Fanconi Anemia Patients Who Receive Transplants: Implications for Future Studies
TL;DR: Historical adverse event rates from long-term follow-up of 117 Fanconi anemia patients in the Hôpital Saint Louis transplant cohort are determined, finding 2-fold reductions from rates and risks observed since the mid-1990s are larger than recently reported case series.
Journal ArticleDOI
HLA-Mismatched Donors in Patients with Myelodysplastic Syndrome: An EBMT Registry Analysis
Marie Robin,Raphaël Porcher,Annalisa Ruggeri,Didier Blaise,Christine Wolschke,Linda Koster,Emanuele Angelucci,Friedrich Stölzel,Victoria T Potter,Ibrahim Yakoub-Agha,Yener Koc,Fabio Ciceri,Jürgen Finke,Hélène Labussière-Wallet,Maria Jesús Pascual Cascon,Mareike Verbeek,Alessandro Rambaldi,Jan J. Cornelissen,Patrice Chevallier,Rohini Radia,Arnon Nagler,Nathalie Fegueux,Eliane Gluckman,Theo de Witte,Nicolaus Kröger +24 more
TL;DR: Patients with myelodysplastic syndrome who have been transplanted from a haploidentical donor using PTCy, an HLA-mismatched unrelated donor (marrow or peripheral blood stem cells), or an unrelated mismatched CB donor have significantly better outcome than those receiving hematopoietic stem cell transplantation from a CB donor.